| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 2108 |
| 1 | ADALIMUMAB | 2053 |
| 2 | METHOTREXATE | 1872 |
| 3 | ETANERCEPT | 1754 |
| 4 | LEFLUNOMIDE | 1627 |
| 5 | TOCILIZUMAB | 1589 |
| 6 | SULFASALAZINE | 1433 |
| 7 | ABATACEPT | 1375 |
| 8 | INFLIXIMAB | 1255 |
| 9 | RITUXIMAB | 1243 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE | 1 | 0.5000 |
| 1 | TRICLOSAN | 95 | 0.1646 |
| 2 | CAFFEINE CITRATE | 254 | 0.1088 |
| 3 | ZINGIBER OFFICINALE | 7 | 0.0805 |
| 4 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 51 | 0.0775 |
| 5 | CLEAR MINT, GEL TOOTHPASTE | 78 | 0.0711 |
| 6 | SODIUM FLUORIDE F18 | 78 | 0.0706 |
| 7 | SODIUM FLUORIDE F-18 | 78 | 0.0704 |
| 8 | BACITRACIN AND POLYMYXIN B SULFATE | 1 | 0.0667 |
| 9 | TRIPROLIDINE HYDROCHLORIDE | 13 | 0.0667 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 2181 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 1871 |
| 2 | Antirheumatic Agent [EPC] | 1627 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 1617 |
| 4 | Corticosteroid [EPC] | 1528 |
| 5 | Aminosalicylate [EPC] | 1506 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 1375 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1341 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1261 |
| 9 | Vitamin C [EPC] | 1095 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 121 | 0.1759 |
| 1 | Endoglycosidase [EPC] | 142 | 0.0766 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 257 | 0.0295 |
| 3 | Interleukin-17A Antagonist [EPC] | 836 | 0.0224 |
| 4 | Provitamin D2 Compound [EPC] | 638 | 0.0214 |
| 5 | Antirheumatic Agent [EPC] | 1627 | 0.0154 |
| 6 | Aminosalicylate [EPC] | 1506 | 0.0149 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 1617 | 0.0117 |
| 8 | Interleukin-6 Antagonist [EPC] | 7 | 0.0108 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 1375 | 0.0098 |